CYTO - Bathi resik saben saham (EPS TTM) Altamira Therapeutics Ltd
Altamira Therapeutics (CYTO) maintains a stable image in the biotech sector based on confidence in its RNA delivery system. Growth is driven by licensing deals and the integration of Peptide+ into partner formulas. The rolling annual earnings per share on this GURU.Markets chart confirms this, where 1.81 shows the current value of the metric. Resilience to crises is guaranteed by the demand for allergy medications across any market cycle.
Ringkesan rincian data analitis Altamira Therapeutics Ltd (CYTO)
- rega saham lan prakiraan rega para ahli:
- statistik kapitalisasi pasar:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Altamira Therapeutics|CYTO - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Auris Medical|CYTO - Utang perusahaan|Utang marang nilai buku Altamira Therapeutics Ltd.|CYTO - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Altamira Therapeutics|Likuiditas cepet altamiratherapeutics.com
- indikator pendapatan resik lan kelipatan nilai:
CYTO - Penghasilan resik|Proyeksi bathi mangsa ngarep Altamira Therapeutics|CYTO - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Auris Medical|CYTO - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Altamira Therapeutics Ltd.|CYTO - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Altamira Therapeutics|CYTO - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan altamiratherapeutics.com|CYTO - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Altamira Therapeutics
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental perusahaan:altamiratherapeutics.com - CYTO
Altamira Therapeutics (CYTO) maintains a strong position in the R&D segment through the development of peptide nanoparticles for RNA delivery. This indicator measures net income allocated per share, excluding the impact of capital structure. Investors utilize this balance to assess the real efficiency of the business prior to licensing deals with pharma behemoths. The positive trend confirms the issuer's financial stability. The annual net income per share price action reflects the company's reaction to market shocks.
Karo sapa Altamira Therapeutics saingan
HLN: Bathi resik saben saham sajrone 12 wulan pungkasan|kenvue.com - Bathi saben saham sajrone patang kuartal pungkasan|VRNA: Bathi resik saben saham (EPS TTM)|Jyong Biotech Limited - Bathi saben saham sajroning taun lumaku|LGND (Ligand Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Amneal Corp AMRX|Bathi saben saham sajrone rolas wulan pungkasan Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) LQDA (Liquidia)|Bathi resik saben saham (EPS TTM) Galapagos N.V. GLPG|ANIP - Bathi saben saham sajrone rolas wulan pungkasan|MNKD: Bathi saben saham sajrone rolas wulan pungkasan|AMPH (Amphastar Pharmaceuticals) - Bathi resik saben saham sajrone 12 wulan pungkasan|PCRX: Bathi saben saham sajrone patang kuartal pungkasan|SPRY (ARS Pharmaceuticals, Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Theravance Biopharma Inc|Bathi saben saham sajrone rolas wulan pungkasan Aquestive Pharma (AQST)|Bathi resik saben saham sajrone 12 wulan pungkasan scpharmaceuticals.com SCPH|Bathi resik saben saham (EPS TTM) TECX (Tectonic Therapeutic)|Bathi resik saben saham sajrone patang kuartal pungkasan tonixpharma.com (TNXP)|SXTC - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku EPRX (Eupraxia Pharmaceuticals)|BHST: Bathi resik saben saham (EPS TTM)|Invizyne (EXOZ) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan ORMP|ENTX: Bathi saben saham sajroning taun lumaku|Bathi resik saben saham sajrone 12 wulan pungkasan HYFT (MindWalk Holdings Inc.)|Bathi saben saham sajrone patang kuartal pungkasan ABVC|Bathi resik saben saham (EPS TTM) CPIX (Cumberland Pharma)|Bathi saben saham sajroning taun lumaku QNTM|FibroGen, Inc. - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan telomirpharma.com|ranitherapeutics.com (RANI) - Bathi saben saham sajrone rolas wulan pungkasan|Synergy CHC - Bathi saben saham sajroning taun lumaku|RLYB (Rallybio Corp) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Lexaria|Bathi saben saham sajrone rolas wulan pungkasan Pulmatrix, Inc. (PULM)|PTHL: Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) APM (Aptorum Group)|Lyra Therapeutics Inc. (LYRA) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|IBO: Bathi resik saben saham sajrone 12 wulan pungkasan|TNFA - Bathi resik saben saham (EPS TTM)|YCBD (cbdmd.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|PRFX: Bathi saben saham sajrone patang kuartal pungkasan|LIPO (Lipella Pharmaceuticals, Inc.) - Bathi resik saben saham (EPS TTM)|OptiNose Inc (OPTN) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) PIRS|Bathi resik saben saham sajrone 12 wulan pungkasan Procaps Group Corp PROC|Bathi saben saham sajrone rolas wulan pungkasan Petros Pharmaceuticals PTPI|Bathi resik saben saham sajrone patang kuartal pungkasan qlsyy.net (QLI)|ACELYRIN - Bathi resik saben saham (EPS TTM)|TFF Pharmaceuticals Inc. (TFFP) - Bathi resik saben saham sajrone 12 wulan pungkasan
